Oclacitinib
Who holds supplier records for Oclacitinib? 1 organisation holds a current record for Oclacitinib: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 3 Aug 2026. How we read these records
Reading the evidence
- One current record
One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (1)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Oclacitinib. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALMELO PRIVATE LTDIndiaActive DMF 43697 · latest filing Apr 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Overview
Oclacitinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103874).
Record history
PharmaTek records which organisations hold a current DMF or CEP for Oclacitinib every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.
Monitoring pilot: get an email when these records change. Places are confirmed by a person; nothing is sent until then. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Oclacitinib?
1 organisation holds an active US FDA Type II Drug Master File or a CEP for Oclacitinib: ALMELO PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Oclacitinib Drug Master Files are active?
ALMELO PRIVATE LTD (DMF 43697). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Oclacitinib supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Oclacitinib?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.